scispace - formally typeset
J

Julie Hawkins

Researcher at GlaxoSmithKline

Publications -  30
Citations -  1307

Julie Hawkins is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Amyloid precursor protein & Amyloid precursor protein secretase. The author has an hindex of 19, co-authored 30 publications receiving 1257 citations.

Papers
More filters
Journal ArticleDOI

Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.

TL;DR: A selective non‐peptidic BACE‐1 inhibitor is designed, GSK188909, that potently inhibits β‐cleavage of APP and reduces levels of secreted and intracellular Aβ in SHSY5Y cells expressing APP and can effectively lower brain Aβin vivo.
Journal ArticleDOI

Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.

TL;DR: A relationship between position and depth of the electrostatic minima relative to the azabicyclic ring and the potency and efficacy of the compounds was determined.
Journal ArticleDOI

Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands.

TL;DR: These compounds provide muscarinic ligands with high potency and a range of efficacies suitable for testing as candidate drugs in the treatment of Alzheimer's disease.
Journal ArticleDOI

Characterization of the Ectodomain Shedding of the β-Site Amyloid Precursor Protein-cleaving Enzyme 1 (BACE1)

TL;DR: This work confirms that the ectodomain of BACE1 is secreted from cells and that this processing is up-regulated by agents that activate protein kinase C, and shows that ADAM10 is a strong candidate for the Bace1 sheddase.